Endocrinology and Metabolism

The Korean Endocrine Society (대한내분비학회)
권호 표지

A Case of Parathyroid Carcinoma Underwent Radiation Therapy on the Metastatic Bone Lesions

골전이를 동반한 부갑상선암에서 전이성 골병변에 방사선요법을 시행한 1예

Lee, Jun-Ho;Kim, Young-Min;Hwang, Dae-Seong;Hwang, Young-Tae;Eum, Jun-Bum;Seo, Jung-Min;Choi, Dae-Hwa;Kang, Byeong-Seong;Noh, Young-Ju;NamGoong, Il-Seong;Kim, Young-Il;Kim, Eun-Sook
이준호;김영민;황대성;황영태;음준범;서정민;최대화;강병성;노영주;남궁일성;김영일;김은숙

  • Published : 20071000
⟨ Previous Next ⟩

Abstract

Parathyroid carcinoma is a rare malignancy that is responsible for only 0.5 to 4% of all cases of primary hyperparathyroidism. Surgery is the only curative treatment. We report a case of a 46-year-old woman referred for a severe osteoporosis with frequent bone fracture associated with hypercalcemia. Initially, though she had multiple osteolytic lesions, we thought that the lesions were brown tumors resulting from hyperparathyroidism. The patient underwent surgery and was diagnosed with parathyroid carcinoma. After surgery, her intact PTH level normalized for brief period of time, but it was again elevated at 6 weeks after surgery. We suggest that the multiple osteolytic lesions were metastases because there was no evidence of local recurrence of parathyroid carcinoma, and the lesions looked like metastases on CT and PET-CT. The patient was treated with radiation therapy on the lumbar vertebra, one a site of the metastatic lesions. After radiotherapy, her serum intact PTH was decreased.

저자들은 특별한 외상없이 중수골의 골절이 생겼고 피로감과 다발성 관절통 및 요통 등의 증상을 보인 여자 환자에서 심한 골감소 및 다발성 골용해 병변과 부갑상선 종괴를 발견하고, 부갑상선 종괴를 동측의 갑상선과 함께 절제하여 부갑상선암을 진단하였으며, 수술 후 혈중 칼슘과 부갑상선 호르몬의 정상화까지 보였으나, 수술 6주 경과 후 혈중 칼슘과 부갑상선 호르몬이 증가하여 다발성 골용해 병변을 부갑상선암의 전이병소로 임상적 진단을 하고 골 병변에 대한 방사선 요법을 시행하여 부갑상선 호르몬이 감소한 환자의 1예를 경험하였기에 보고한다.

Keywords

References

  1. Ruda JM,IIollenbeak CS, Stack BC Jr: A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 132:359-372, 2005 https://doi.org/10.1016/j.otohns.2004.10.005
  2. Wynne AG, Van Heerden J, Carney JA, Fitzpatrick LA: Parathyroid carcinoma: clinical and pathologic features in 43 patients. Medicine 71:197-205, 1992 https://doi.org/10.1097/00005792-199207000-00002
  3. Choi YK, Lee JS, Kim IIW, Kim YM, Son SM, Kim IJ, Kim YK, Chae HJ: A case of parathyroid carcinoma invading thyroid gland as solitary nodular form. J Kor Soc Endocrinol 14:171-176, 1999
  4. Kang MS, Lee HY, Seo PJ, Seo HJ, Kwon MS: A case of ectopic parathyroid carcinoma presenting with renal failure and anemia. Kor J Intern Med 71:435-441, 2006
  5. Rao SR, Shaha AR, Singh B, Rinaldo A, Ferlito A: Management of cancer of the parathyroid. Acta Oto-Laryngol 122:448-452, 2002 https://doi.org/10.1080/00016480260000184
  6. Hundahl SA, Fleming ID, Fremgen AM, Menck HR: Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: A National Cancer Data Base report. Cancer 86:538-544, 1999 https://doi.org/10.1002/(SICI)1097-0142(19991115)86:10<1985::AID-CNCR15>3.0.CO;2-H
  7. Shane E: Clinical review 122: parathyroid carcinoma. J Clin Endocrinol Metab 86:485-493, 2001 https://doi.org/10.1210/jc.86.2.485
  8. Kebebew E: Parathyroid carcinoma. Curr Treat Options Oncol 2:347-354, 2001 https://doi.org/10.1007/s11864-001-0028-2
  9. Clayman GL, Gonzalez HE, El-Naggar A, VassilopoulouSellin R: Parathyroid carcinoma: evaluation and Interdisciplinary Management. Cancer 100:900-905, 2004 https://doi.org/10.1002/cncr.20089
  10. Munson ND, Foote RL, Northcutt RC, Tiegs RD, Fitzpatrick LA, Grant CS, Van Heerden JA, Thompson GB, Lloyd RV: Parathyroid carcinoma: is there a role for adjuvant radiation therapy? Cancer 98:2378-2384, 2003 https://doi.org/10.1002/cncr.11819
  11. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, BeckPeccoz P, Bordi C, Conte- Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells SA Jr, Marx SJ: Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658-5671, 2001 https://doi.org/10.1210/jc.86.12.5658
  12. Favia G, Lumachi F, Polistina F, D'Amico DF: Parathyroid carcinoma: sixteen new cases and suggestions for correct management. World J Surg 22: 1225-1230, 1998 https://doi.org/10.1007/s002689900549
  13. Kleinpeter KP, Lovato JF, Clark PB, Wooldridge T, Norman ES, Bergman S, Perrier ND: Is parathyroid carcinoma indeed a lethal disease? Ann Surg Oncol 12:260-266, 2005 https://doi.org/10.1245/ASO.2005.03.036
  14. Ryu CS, Kim DK, Park KH, Seong SG, Kim DH, Woo SM, Cho IS: A case of primary parathyroid carcinoma with full-brown symptom. J Kor Soc Endocrinol 11:221-226. 1996
  15. Grimelius L, Johansson H: Pathology of parathyroid tumors. Semin Surg Oncol 13:142-154, 1997 https://doi.org/10.1002/(SICI)1098-2388(199703/04)13:2<142::AID-SSU10>3.0.CO;2-0
  16. Koea JB, Shaw JH: Parathyroid cancer: Biology and management. Surg Oncol 8:155-165, 1999 https://doi.org/10.1016/S0960-7404(99)00037-7
  17. Oh SK, Park YH, Kim JH, Lee MS, Min HK: Multiple primary parathyroid carcinoma. J Kor Surg Soc 39:546-553, 1990
  18. Pai M, Park CH, Kim BS, Chung YS, Park HB: Multiple brown tumors in parathyroid carcinoma mimicking metastatic bone disease. Clin Nucl Med 22:691-694, 1997 https://doi.org/10.1097/00003072-199710000-00006
  19. Rasmuson T, Kristoffersson A, Boquist L: Positive effect of radiotherapy and surgery on hormonally active pulmonary metastases of primary parathyroid carcinoma. Eur J Endocrinol 143:749-754, 2000 https://doi.org/10.1530/eje.0.1430749
  20. Bukowski RM, Sheeler L, Cunningham J, Esselstyn C: Successful combination chemotherapy for metastatic parathyroid carcinoma. Arch Intern Med 144:399-400, 1984 https://doi.org/10.1001/archinte.144.2.399